Corecivic, INC 10-Q quarterly reports

CoreCivic, Inc. announced robust Q2 2026 results with significant revenue increases driven by federal contracts and the acquisition of Clinical Solutions Pharmacy, alongside the completion of substantial facility sales.

CoreCivic, Inc. announced a significant increase in net income and revenue for the first quarter of 2026, primarily driven by expanded federal contracts and improved occupancy rates.

CoreCivic, Inc. reported significantly increased net income and revenue for Q3 and the first nine months of 2025, driven by new contracts and facility activations with U.S. Immigration and Customs Enforcement.

CoreCivic reports significant Q2 2025 financial growth, driven by increased federal demand and strategic facility activations, despite ongoing labor challenges.

CoreCivic's Q1 2025 results show a net income increase driven by renewed ICE contracts and strategic facility management.

CoreCivic, Inc. reported its third quarter 2024 financial results, highlighting a complex period marked by contract terminations, new business agreements, and ongoing challenges in the labor market.

CoreCivic's second quarter results show a net income increase, but are overshadowed by a significant contract termination and debt refinancing activities.

CoreCivic's first quarter 2024 results show a 9.3% increase in revenue, driven by higher occupancy and per diem rates, alongside significant debt refinancing activities.